Evidence map›Paper›PMID 37882822›Full record

ArticleEuropean journal of pediatrics2024

Increased rates of invasive bacterial disease in late 2022.

Sarah Kyne, Doireann Ní Shíocháin, Caoimhe McDonnell, Aisling Byrne, Una Sutton-Fitzpatrick, Niamh Crowley, Leona Nertney, Conor Myers, John Waldron, Aneeq Ahmed and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sarah KyneGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland. kynes@tcd.ie.ORCID http://orcid.org/0000-0002-1922-7278
Doireann Ní ShíocháinEmergency Medicine, Children's Health Ireland, Dublin, Ireland.
Caoimhe McDonnellRadiology, Children's Health Ireland, Dublin, Ireland.
Aisling ByrneGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.
Una Sutton-FitzpatrickClinical Microbiology, Children's Health Ireland, Dublin, Ireland.
Niamh CrowleyGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.
Leona NertneyGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.
Conor MyersGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.
John WaldronRadiology, Children's Health Ireland, Dublin, Ireland.
Aneeq AhmedRadiology, Children's Health Ireland, Dublin, Ireland.
Caragh WrynneGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.
Jerome FennellClinical Microbiology, Children's Health Ireland, Dublin, Ireland.
Patrick FitzpatrickEmergency Medicine, Children's Health Ireland, Dublin, Ireland.
John J FitzsimonsGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.
Barry ScanlanGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.
David VaughanGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.
Kathleen M GormanNeurology, Children's Health Ireland, Dublin, Ireland.
Robert CunneyClinical Microbiology, Children's Health Ireland, Dublin, Ireland.
Anna E SmythRadiology, Children's Health Ireland, Dublin, Ireland.
Jonathan O'B HourihaneGeneral Paediatrics, Children's Health Ireland, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive bacterial disease is associated with significant morbidity and mortality. In winter 2022, there was an apparent increased rate of invasive bacterial disease compared to preceding years. Cross-site retrospective analysis of the three Children's Health Ireland (CHI) hospitals looking at children admitted between 1st October 2022-31st December 2022 (Q4) with community-acquired invasive bacterial disease, defined as an abscess in a normally sterile site in the head, neck and chest or isolation or PCR detection of Streptococcus pneumoniae, Neisseria meningitidis, Streptococcus pyogenes (Group A streptococcus) or Haemophilus influenzae from a normally sterile site. Case numbers were compared to Q4 in each of 2018-2021. Eighty-two children met the case definition in Q4 2022 vs 97 (Q4 2018-2021). In 2022, 42/82 (51%) were female, median age 3.75 years (1.5-8.25 years). Only 2 (2%) were immunosuppressed and 2 others (2%) had underlying neurodisability. Fifty (61%) were admitted on second or subsequent presentation to a healthcare setting. Fifty-six (68%) had an abscess in a sterile site. Bloodstream infection (positive blood culture or PCR: 24 (29%)) was the most common site of infection, followed by neck 22 (27%) and intracranial 12 (15%). Group A streptococcus (GAS) 27 (33%) was the most common organism isolated. Seven cases (9%) died in 2022 compared to 2 patients (2%) from 2018 to 2021 (p < 0.05). More children had Paediatric Overall Performance Category (POPC) scores > 1 in 2022 than 2018-2021 (p = 0.003).  Conclusion: Invasive bacterial diseases increased in Q4 2022 with higher morbidity and mortality than in the preceding 4 years. Group A streptococcal infection was the most significant organism in 2022. What is known: • Invasive bacterial disease is the leading cause of childhood mortality globally. • There was an increase in cases of invasive Group A streptococcus infections reported in many countries (including Ireland) during the winter of 2022/23. What is new: • Head, neck and chest abscesses increased in Q4 of 2022 compared to the previous 4 years combined. • Invasive bacterial infections in Q4 of 2022 were associated with higher rates of mortality (9%), paediatric intensive care unit (PICU) admission (24%) and requirement for surgical drainage or intervention (67%) than in the preceding years.

Indexed as

Neisseria meningitidisStreptococcal InfectionsAbscessChildChild, PreschoolFemaleHumansInfantMaleRetrospective StudiesStreptococcus pneumoniaeAbscessGroup A StreptococcusInvasive bacterial diseasePandemic

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.